投资增长股 - 投资者寻找增长股，以利用金融领域的高于平均增长，帮助这些证券吸引市场关注并产生异常回报[1] - 利用Zacks Growth Style Score可以轻松找到前沿增长股，该评分系统超越传统增长属性，分析公司的真实增长前景[3] - Cardinal Health (CAH)是一家公司，我们的专有系统目前推荐的股票之一，不仅具有有利的增长评分，还具有顶级的Zacks Rank[4] 公司增长指标 - Cardinal的每股收益预计今年将增长25.8%，远超行业平均水平，这是一个重要的增长指标[7] - Cardinal的资产利用率比行业平均水平高，公司每资产1美元可以获得4.88美元的销售额[9] - Cardinal的销售预计今年将增长10.7%，远超行业平均水平，这也是一个重要的增长指标[10] - Cardinal的当年盈利预期已经上调，过去一个月Zacks对当年的盈利预期上涨了0.1%[12] 公司表现优势 - Cardinal根据多个因素（包括上述因素）获得了A级的Growth Score，这使得公司在表现上处于有利地位，增长投资者可能会选择押注在它身上[13]

Investors care about the bottom line. What does this mean? Well, we want to be looking for companies that are making a profit and growing their earnings at an appealing rate over time. There’s not much appeal in investing in a company that doesn’t have great prospects for improving its earnings. It’s also not too enticing to put our money in a company that can make great revenue but can’t manage to hang on to any of it after all of its costs.Although there are occasions when it can be crucial for companies ...

Zacks Premium - Zacks Premium提供了多种方式帮助投资者更加聪明和自信地投资[1] Zacks Style Scores - Zacks Style Scores是一种辅助指标，与Zacks Rank一起评估股票，根据价值、增长和动量特征对股票进行评级[3] VGM Score - VGM Score结合了三种Style Scores，帮助找到具有最具吸引力价值、最佳增长预测和最有前景动量的公司[8] Style Scores与Zacks Rank结合使用 - Style Scores与Zacks Rank结合使用，选择具有Zacks Rank 1或2且Style Scores为A或B的股票，以确保最大的上涨潜力[12] Cardinal Health (CAH) - Cardinal Health (CAH)是一家总部位于俄亥俄州都柏林的全国性药品分销商，具有Zacks Rank 2 (Buy)和VGM Score为A[15] - CAH具有优秀的动量和VGM Style Scores，应该被列入投资者的观察名单[18]

DUBLIN, Ohio, March 15, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions reduction targets. Targets are considered science-based if they align with what the latest climate science says is necessary to limit global warming to 1.5°C above pre-industrial levels. "We are committed to reducing our impact on the environment and contributing to a more ...

Undervalued stocks are typically always a solid investment option in a bullish or bearish market due to the fact that they offer considerable upside. Solid fundamentals are the backbone of a company’s overall success. Some stocks may be able to experience growth for a select period of time due to increased investor interest, but for long-term stable returns, companies with consistent earnings potential will always be a much better option.Here are a few solid companies from multiple sectors that have seen a ...

公司战略 - 公司的战略重点是如何增长制药和专业业务[12] - 公司希望在未来五年内建立制药和专业业务的增长引擎[43] - 公司强调在药品和专业业务领域的核心业务增长[44] 资本分配和价值创造 - 公司将继续在资本分配方面保持明智活跃，预计未来几年将有更多机会[41] - 公司通过适当管理资产和资源，不懈地提供股东价值创造[15] 新产品和技术研发 - 公司介绍了Navista网络，旨在为独立的肿瘤学家提供服务[48] - 公司通过Red Oak网络支持创新，确保患者以合理的成本获得药品[57] 市场扩张和并购 - 公司在2023财年的全球医疗产品和分销业务中取得了1650万美元的亏损，预计在2026财年将实现约6500万美元的利润[76] 负面信息 - 品牌制造商的价格上涨对公司业务影响较小，主要集中在财政第三季度[54] - 公司对通用药短缺的调查持谨慎态度，视之为机会而非风险[58]

Cardinal Health, Inc. (NYSE:CAH) Barclays 26th Annual Global Healthcare Conference March 13, 2024 8:30 AM ET Company Participants Matt Sims - Head, Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Stephanie Davis - Barclays Capital Stephanie Davis All right. Good morning everyone. Thank you for going bright and early with us. I am delighted to have Cardinal here to kick off our day. We have the CFO, Aaron Alt and with Head of IR, Matt Sims who's also going to keep Aaron in ...

公司表现 - Cardinal Health, Inc. (CAH) 于3月8日创下了新的52周高点，股价达到115.38美元[1] - 过去一年，CAH股价上涨了64.3%，远高于行业的18.3%增长和标普500指数的32.9%涨幅[2] - Cardinal Health过去五年的盈利增长为2.1%，低于行业的12.8%增长，但长期预期增长率为14.2%，高于行业的11.6%[3] 产品组合 - 公司股价上涨的原因之一是其多样化的产品组合，特别是医疗和制药产品[6] - 公司在医疗领域的其他关键选择包括DaVita Inc. (DVA)、Zimmer Biomet Holdings, Inc. (ZBH)和Cencora, Inc. (COR)[13] 业绩展望 - CAH在第二季度财年2024表现强劲，开设了几家分销中心，这些因素预计将进一步推动公司发展[4] - Cardinal Health面临失去主要客户的风险，如果失去一个主要客户，将严重影响未来收入[11]

Even though inflation in the United States has declined sharply, it remains above the Federal Reserve’s 2% target. Due to the hotter-than-expected January inflation reading, consumer sentiment took a beating. The University of Michigan’s consumer sentiment survey displayed a reading of 76.9 in February, down from the January figure of 79.Fed Chair Jerome Powell's recent statement that he needs to "see a little bit more data" before rate cuts become a reality highlights that interest rates will remain high, ...

Dividend investing remains a popular choice, irrespective of market conditions. This strategy focuses on companies that not only pay dividends but also consistently increase them over time. This approach offers a unique blend of income and growth potential, appealing to a broad range of investors. Additionally, it provides a sense of security in times of market uncertainty or downturns, as dividend-paying stocks can reduce the volatility of a portfolio and tend to outperform in a choppy market.Stocks with a ...